The Effect of Low-dose Interleukin-2 on the Immune Landscape of Human Atherosclerotic Plaques at Single Cell Resolution.
Conditions: TIA; Carotid Artery Plaque; Carotid Atherosclerosis Interventions: Drug: Interleukin-2 [IL-2]; Procedure: Standard care - Carotid Endarterectomy Sponsor: Cambridge University Hospitals NHS Foundation Trust Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials